(Updated - May 2, 2023 7:41 AM EDT)

Harmony Biosciences (NASDAQ: HRMY) reported Q1 EPS of $0.66, $0.18 better than the analyst estimate of $0.48. Revenue for the quarter came in at $119.13 million versus the consensus estimate of $120.61 million.

For earnings history and earnings-related data on Harmony Biosciences (HRMY) click here.

Earnings